TXG
2026 data Public-data reference. official source

10x Genomics, Inc.

Open-data reference.

Measuring Instruments · DE · FY2023
CEO-to-Worker Pay Ratio
37:1
Below Average (Scale: 0–1000:1)
CEO Pay
$8.3M
Median Worker
$223,138
Compensation Pillar

CEO compensation breakdown — pay ratio 37× median worker (Dodd-Frank §953(b) disclosure)

CompensationBase salaryBonusEquityPerksPension
CEO compensation breakdown — pay ratio 37× median worker (Dodd-Frank §953(b) disclosure)

10x Genomics, Inc., a measuring instruments company, reported a CEO-to-worker pay ratio of 37:1 in FY2023. CEO received total compensation of $8.3M, while the median employee earned $223,138 annually. This is below the Measuring Instruments industry median of 108:1 across 98 companies. Data sourced from SEC EDGAR proxy (DEF 14A) filings.

CEO Compensation Breakdown — FY2023

Detailed breakdown not available.

CEO compensation components for 10x Genomics, Inc. in fiscal year 2023 as disclosed on SEC EDGAR Form DEF 14A.
Component Amount (USD)
Base Salary
Bonus
Stock Awards
Option Awards
Non-Equity Incentive Plan
Pension Value Change
Other Compensation
Total Compensation$8.3M

Source: SEC EDGAR Form DEF 14A — CIK 1770787, FY2023 Summary Compensation Table.

Industry Comparison — Measuring Instruments

This Company's Ratio
37:1
Industry Median Ratio
108:1
Industry Median CEO Pay
$8.4M
This CEO's Pay
$8.3M
Companies in Industry
98
vs. Industry Median
Below
View all companies in Measuring Instruments →

Understanding This Pay Ratio

10x Genomics, Inc.'s CEO-to-worker pay ratio of 37:1 means that earned 37 times more than the company's median employee in FY2023.

The median employee at 10x Genomics, Inc. earned $223,138 annually. At that wage, it would take a median employee approximately 37 years to earn what the CEO earned in a single year.

CEO Total Pay

$8.3M

FY2023 Summary Compensation

Pay Ratio

37:1

Below typical industry median

Disclosure Transparency

1.0/5

Limited pay component reporting

Pay-Versus-Performance Disclosure

Under 17 CFR §229.402(v) (the Pay-Versus-Performance rule effective for fiscal years ending after December 16, 2022), issuers must reconcile Compensation Actually Paid (CAP) to Total Shareholder Return (TSR) over a multi-year window. The chart below visualizes the relationship between 10x Genomics, Inc.'s reported CAP and TSR for FY2023.

Pay vs Performance — FY2023 (Dodd-Frank §953(a) PvP disclosure)

TSR (%)0CAP realized ($M)8.286049CAP granted ($M)8.286049
Pay vs Performance — FY2023 (Dodd-Frank §953(a) PvP disclosure)

Pay Composition

Equity-based pay (stock + options) 0.0%
Performance-linked (incentive + bonus) 0.0%
Fixed compensation (base salary) 0.0%

ISS QualityScore and Glass-Lewis voting guidelines weight performance-linked share of pay. The CII (Council of Institutional Investors) recommends ≥50% of CEO pay be tied to multi-year performance metrics.

What This 2023 Filing Tells Us About 10x Genomics, Inc.

According to the 2023 DEF 14A proxy statement filed with the SEC, 10x Genomics, Inc. (TXG, CIK 1770787) reported CEO 's total compensation at $8.3M. That figure is an aggregate of base salary (N/A). The median employee at the firm — the reference point mandated by Section 953(b) of the Dodd-Frank Act — earned $223,138 over the same fiscal year, producing the headline CEO-to-worker pay ratio of 37:1 that this page tracks.

Context matters when reading this ratio. 10x Genomics, Inc. operates in the Measuring Instruments sector and is headquartered in DE. Across the Measuring Instruments industry (SIC 38), 98 SEC-reporting companies disclosed pay ratios in FY2023, with a median of 108:1 and an average of 168:1. Median industry CEO pay was $8.4M, so 10x Genomics, Inc.'s $8.3M sits at or below that typical figure. That comparison is the fastest way to separate "the CEO is paid like peers" from "this company is an outlier."

Finally, a note on what these SEC numbers do and do not include. Total compensation reported under Item 402 of Regulation S-K reflects grant-date fair value for equity awards, not realized pay, so a CEO may eventually cash in more — or less — depending on stock performance and vesting. The pay ratio itself is calculated against a single median employee chosen under rules that allow statistical sampling, and companies may update methodology year to year. This proxy was filed on 2024-04-26; all figures on this page come directly from that public filing and can be verified against the DEF 14A on the SEC EDGAR system.

Key Data — FY2023

CEO
Total Compensation
$8.3M
Base Salary
N/A
Median Employee Pay
$223,138
Pay Ratio
37:1
Filing Date
2024-04-26

Company Info

Ticker
TXG
CIK
1770787
Industry
Measuring Instruments
SIC Code
3826
State
DE
Data Source: This data is sourced from SEC EDGAR proxy statement (DEF 14A) filings. PlainCEOPay provides this publicly available information for informational purposes only. Not investment or financial advice. Verify with official SEC filings at sec.gov.

Frequently Asked Questions

What is the CEO pay ratio at 10x Genomics, Inc.?
10x Genomics, Inc.'s CEO-to-worker pay ratio is 37:1. CEO null earned $8.3M in FY2023, while the median employee earned $223,138.
How much does 10x Genomics, Inc.'s CEO earn?
null, CEO of 10x Genomics, Inc. (TXG), earned total compensation of $8.3M in fiscal year 2023, according to SEC proxy filings.
How does 10x Genomics, Inc.'s pay ratio compare to its industry?
10x Genomics, Inc.'s pay ratio of 37:1 is below the Measuring Instruments industry median of 108:1. The industry has 98 companies reporting pay ratios.
Where does 10x Genomics, Inc.'s CEO pay data come from?
All executive compensation data is sourced from SEC EDGAR DEF 14A proxy statement filings. Companies are required by the Dodd-Frank Act to disclose CEO-to-median-worker pay ratios annually. PlainCEOPay aggregates this publicly available data for easy comparison.
What is included in null's total compensation?
Total compensation of $8.3M includes base salary, stock awards, option awards, non-equity incentive plan compensation, pension value changes, and other compensation as reported in the proxy filing summary compensation table.
How long would it take a median 10x Genomics, Inc. employee to earn the CEO's pay?
At a median salary of $223,138, it would take the typical 10x Genomics, Inc. employee approximately 37 years to earn what CEO null earned in a single year ($8.3M in FY2023).
All federal data sources used on this page

Related

Data sourced from $official public datasets. See our methodology for details. Retrieved and formatted by PlainCEOPay Editorial